Literature DB >> 17895763

Adenomyomatous hyperplasia of the gallbladder with perineural invasion: revisited.

Jorge Albores-Saavedra1, Brent Keenportz, Pablo A Bejarano, Alan A Z Alexander, Donald E Henson.   

Abstract

We report 9 examples of segmental adenomyomatous hyperplasia of the gallbladder with perineural invasion. Five patients were women and 4 men. Their ages ranged from 49 to 81 years (mean age 64 y). Eight patients had gallbladder calculi. The original pathologic diagnosis of adenocarcinoma was made in 5 patients and of "adenoma malignum" in one. Six patients are disease-free for 2 to 11 years following cholecystectomy, 1 patient died of unrelated causes and 2 were lost to follow-up. Histologically 2 types of adenomyomatous hyperplasia were recognized. The first one characterized by numerous Rokitansky-Aschoff sinuses (RASs) was accompanied by smooth muscle hyperplasia and an expanded subserosal layer containing numerous nerve trunks (6 cases). The second type was characterized by an extensively fibrotic gallbladder wall with numerous RASs but with few or no smooth muscle bundles and an expanded subserosal layer containing abundant nerve-trunks (3 cases). Perineural (7 cases) and intraneural invasion (2 cases) was identified only in the subserosal layer. The lack of p53 reactivity and the very low MIB-1-labeling index provide additional support to the non-neoplastic nature of the lesion. The pseudoinvasive pattern of the RASs, reactive epithelial atypia, and the perineural and intraneural invasion probably contributed to the erroneous diagnosis of adenocarcinoma or "adenoma malignum." The mechanism by which the epithelial structures "invaded" the perineural spaces and the nerves is unclear. We favor the hypothesis that the migration of the benign glandlike structures into the nerves is related to the production of chemotactic factors or signaling substances and the activation of cell receptors.

Entities:  

Mesh:

Year:  2007        PMID: 17895763     DOI: 10.1097/PAS.0b013e31804fa10e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Hyperplastic Luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa.

Authors:  Aatur D Singhi; Nazmi Volkan Adsay; Sharon L Swierczynski; Michael Torbenson; Robert A Anders; Ralph H Hruban; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

2.  Histopathologic features and frequency of gall bladder lesions in consecutive 540 cholecystectomies.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

3.  Gallbladder sarcoma: a clinicopathological study of seven cases from the UK and Austria with emphasis on morphological subtypes.

Authors:  E A Husain; R J Prescott; S A Haider; R W T Al-Mahmoud; B G Zelger; B Zelger; Wael I Al-Daraji
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

Review 4.  Telocytes in the Normal and Pathological Peripheral Nervous System.

Authors:  Lucio Díaz-Flores; Ricardo Gutiérrez; Mª Pino García; Sara Gayoso; Emma Gutiérrez; Lucio Díaz-Flores; José Luis Carrasco
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

5.  Morphological and immunophenotypical analysis of the spindle cell component in adenomyomatous hyperplasia of the gallbladder.

Authors:  Kritika Krishnamurthy; Christopher A Febres-Aldana; Steven Melnick; Vathany Sriganeshan; Robert J Poppiti
Journal:  Pathologica       Date:  2021-08

6.  Intracystic papillary neoplasm with an associated mucinous adenocarcinoma arising in Rokitansky-Aschoff sinus of the gallbladder.

Authors:  Ryuichiro Sato; Toshinori Ando; Hiroo Tateno; Toshiki Rikiyama; Toru Furukawa; Nobuo Ebina
Journal:  Surg Case Rep       Date:  2016-06-18

7.  Histopathological study of gallbladder carcinoma and its mimics with role of carcinoembryonic antigen immunomarker in resolving diagnostic difficulties.

Authors:  Santosh Kumar Mondal; Debashish Bhattacharjee; Palash Kumar Mandal; Saumitra Biswas
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.